Unresolved disorder model. using A ATOM 153 N AVAL 21 9.304 -31.040 -3.185 0.60 15.74 N Unresolved disorder model. using A ATOM 154 N BVAL 21 9.405 -31.018 -3.300 0.40 14.20 N Unresolved disorder model. using A ATOM 155 CA AVAL 21 9.117 -29.675 -3.728 0.60 15.36 C Unresolved disorder model. using A ATOM 156 CA BVAL 21 9.349 -29.610 -3.758 0.40 12.44 C Unresolved disorder model. using A ATOM 157 C AVAL 21 7.995 -29.004 -2.990 0.60 15.33 C Unresolved disorder model. using A ATOM 158 C BVAL 21 8.085 -28.965 -3.221 0.40 13.86 C Unresolved disorder model. using A ATOM 159 O AVAL 21 6.877 -29.559 -2.768 0.60 14.46 O Unresolved disorder model. using A ATOM 160 O BVAL 21 6.983 -29.561 -3.310 0.40 13.85 O Unresolved disorder model. using A ATOM 161 CB AVAL 21 8.732 -29.731 -5.239 0.60 16.30 C Unresolved disorder model. using A ATOM 162 CB BVAL 21 9.412 -29.536 -5.283 0.40 11.15 C Unresolved disorder model. using A ATOM 163 CG1AVAL 21 8.655 -28.319 -5.924 0.60 15.92 C Unresolved disorder model. using A ATOM 164 CG1BVAL 21 8.272 -30.479 -5.899 0.40 10.73 C Unresolved disorder model. using A ATOM 165 CG2AVAL 21 9.684 -30.618 -5.960 0.60 20.92 C Unresolved disorder model. using A ATOM 166 CG2BVAL 21 9.308 -28.065 -5.796 0.40 11.10 C Unresolved disorder model. using A ATOM 234 CA AGLU 31 18.794 -36.514 -0.472 0.50 13.24 C Unresolved disorder model. using A ATOM 235 CA BGLU 31 18.792 -36.504 -0.485 0.50 13.82 C Unresolved disorder model. using A ATOM 238 CB AGLU 31 18.363 -37.076 0.893 0.50 15.67 C Unresolved disorder model. using A ATOM 239 CB BGLU 31 18.303 -37.065 0.834 0.50 16.18 C Unresolved disorder model. using A ATOM 240 CG AGLU 31 17.291 -38.179 0.846 0.50 13.44 C Unresolved disorder model. using A ATOM 241 CG BGLU 31 18.066 -36.014 1.931 0.50 17.49 C Unresolved disorder model. using A ATOM 242 CD AGLU 31 16.934 -38.923 2.236 0.50 17.88 C Unresolved disorder model. using A ATOM 243 CD BGLU 31 19.357 -35.298 2.406 0.50 21.86 C Unresolved disorder model. using A ATOM 244 OE1AGLU 31 17.297 -38.499 3.361 0.50 14.23 O Unresolved disorder model. using A ATOM 245 OE1BGLU 31 20.425 -35.855 2.192 0.50 24.07 O Unresolved disorder model. using A ATOM 246 OE2AGLU 31 16.198 -39.950 2.216 0.50 16.56 O Unresolved disorder model. using A ATOM 247 OE2BGLU 31 19.325 -34.152 2.927 0.50 20.05 O Unresolved disorder model. using A ATOM 275 N AGLU 36 14.590 -46.450 -2.950 0.50 22.76 N Unresolved disorder model. using A ATOM 276 N BGLU 36 14.646 -46.391 -3.003 0.50 22.10 N Unresolved disorder model. using A ATOM 277 CA AGLU 36 13.438 -45.780 -2.285 0.50 23.45 C Unresolved disorder model. using A ATOM 278 CA BGLU 36 13.489 -45.859 -2.338 0.50 22.12 C Unresolved disorder model. using A ATOM 279 C AGLU 36 12.482 -46.676 -1.499 0.50 23.17 C Unresolved disorder model. using A ATOM 280 C BGLU 36 12.968 -47.050 -1.561 0.50 20.96 C Unresolved disorder model. using A ATOM 281 O AGLU 36 11.503 -47.231 -2.025 0.50 26.31 O Unresolved disorder model. using A ATOM 282 O BGLU 36 12.779 -48.145 -2.189 0.50 17.18 O Unresolved disorder model. using A ATOM 283 CB AGLU 36 12.603 -44.967 -3.262 0.50 22.46 C Unresolved disorder model. using A ATOM 284 CB BGLU 36 12.449 -45.336 -3.361 0.50 21.91 C Unresolved disorder model. using A ATOM 285 CG AGLU 36 11.422 -44.364 -2.534 0.50 23.14 C Unresolved disorder model. using A ATOM 286 CG BGLU 36 11.635 -44.167 -2.785 0.50 25.43 C Unresolved disorder model. using A ATOM 287 CD AGLU 36 10.453 -43.703 -3.482 0.50 22.21 C Unresolved disorder model. using A ATOM 288 CD BGLU 36 10.662 -43.472 -3.776 0.50 30.31 C Unresolved disorder model. using A ATOM 289 OE1AGLU 36 9.928 -44.391 -4.426 0.50 21.08 O Unresolved disorder model. using A ATOM 290 OE1BGLU 36 10.621 -43.777 -5.011 0.50 28.15 O Unresolved disorder model. using A ATOM 291 OE2AGLU 36 10.264 -42.468 -3.325 0.50 16.53 O Unresolved disorder model. using A ATOM 292 OE2BGLU 36 9.909 -42.593 -3.291 0.50 31.52 O Unresolved disorder model. using A ATOM 374 CA ALYS 47 13.349 -34.319 8.446 0.50 12.37 C Unresolved disorder model. using A ATOM 375 CA BLYS 47 13.321 -34.265 8.545 0.50 12.23 C Unresolved disorder model. using A ATOM 378 CB ALYS 47 14.368 -34.850 7.432 0.50 11.25 C Unresolved disorder model. using A ATOM 379 CB BLYS 47 14.614 -34.630 7.818 0.50 12.78 C Unresolved disorder model. using A ATOM 380 CG ALYS 47 15.321 -35.857 8.089 0.50 14.34 C Unresolved disorder model. using A ATOM 381 CG BLYS 47 15.558 -35.418 8.723 0.50 11.94 C Unresolved disorder model. using A ATOM 382 CD ALYS 47 16.630 -35.809 7.304 0.50 10.73 C Unresolved disorder model. using A ATOM 383 CD BLYS 47 16.852 -35.990 8.020 0.50 13.96 C Unresolved disorder model. using A ATOM 384 CE ALYS 47 16.454 -36.626 6.141 0.50 6.52 C Unresolved disorder model. using A ATOM 385 CE BLYS 47 17.872 -34.846 7.824 0.50 19.43 C Unresolved disorder model. using A ATOM 386 NZ ALYS 47 17.871 -36.673 5.514 0.50 11.39 N Unresolved disorder model. using A ATOM 387 NZ BLYS 47 18.970 -35.007 6.806 0.50 21.89 N Unresolved disorder model. using A ATOM 461 CA AVAL 57 2.316 -34.221 0.952 0.50 17.81 C Unresolved disorder model. using A ATOM 462 CA BVAL 57 2.316 -34.223 0.980 0.50 17.59 C Unresolved disorder model. using A ATOM 465 CB AVAL 57 3.465 -35.077 1.584 0.50 18.76 C Unresolved disorder model. using A ATOM 466 CB BVAL 57 3.348 -35.052 1.738 0.50 18.20 C Unresolved disorder model. using A ATOM 467 CG1AVAL 57 2.994 -36.291 2.407 0.50 16.37 C Unresolved disorder model. using A ATOM 468 CG1BVAL 57 4.236 -35.960 0.824 0.50 17.78 C Unresolved disorder model. using A ATOM 469 CG2AVAL 57 4.546 -35.537 0.511 0.50 17.46 C Unresolved disorder model. using A ATOM 470 CG2BVAL 57 4.274 -34.097 2.564 0.50 14.41 C Unresolved disorder model. using A ATOM 471 N AHIS 58 1.879 -34.766 -1.368 0.70 17.41 N Unresolved disorder model. using A ATOM 472 N BHIS 58 1.883 -34.706 -1.340 0.30 17.65 N Unresolved disorder model. using A ATOM 473 CA AHIS 58 1.429 -35.642 -2.467 0.70 19.30 C Unresolved disorder model. using A ATOM 474 CA BHIS 58 1.565 -35.543 -2.462 0.30 17.64 C Unresolved disorder model. using A ATOM 475 C AHIS 58 2.557 -36.598 -2.743 0.70 17.25 C Unresolved disorder model. using A ATOM 476 C BHIS 58 2.687 -36.623 -2.476 0.30 16.68 C Unresolved disorder model. using A ATOM 477 O AHIS 58 3.634 -36.154 -3.227 0.70 17.54 O Unresolved disorder model. using A ATOM 478 O BHIS 58 3.877 -36.336 -2.398 0.30 15.41 O Unresolved disorder model. using A ATOM 479 CB AHIS 58 1.117 -34.822 -3.708 0.70 20.55 C Unresolved disorder model. using A ATOM 480 CB BHIS 58 1.420 -34.639 -3.713 0.30 17.82 C Unresolved disorder model. using A ATOM 481 CG AHIS 58 -0.072 -33.931 -3.543 0.70 24.83 C Unresolved disorder model. using A ATOM 482 CG BHIS 58 0.361 -33.563 -3.558 0.30 17.84 C Unresolved disorder model. using A ATOM 483 ND1AHIS 58 -1.374 -34.381 -3.714 0.70 31.03 N Unresolved disorder model. using A ATOM 484 ND1BHIS 58 0.219 -32.498 -4.427 0.30 19.33 N Unresolved disorder model. using A ATOM 485 CD2AHIS 58 -0.165 -32.642 -3.138 0.70 27.62 C Unresolved disorder model. using A ATOM 486 CD2BHIS 58 -0.570 -33.370 -2.587 0.30 19.27 C Unresolved disorder model. using A ATOM 487 CE1AHIS 58 -2.217 -33.391 -3.456 0.70 33.65 C Unresolved disorder model. using A ATOM 488 CE1BHIS 58 -0.783 -31.728 -4.036 0.30 16.20 C Unresolved disorder model. using A ATOM 489 NE2AHIS 58 -1.513 -32.327 -3.106 0.70 32.75 N Unresolved disorder model. using A ATOM 490 NE2BHIS 58 -1.285 -32.240 -2.921 0.30 21.14 N Unresolved disorder model. using A ATOM 492 CA ATHR 59 3.373 -38.914 -2.462 0.50 14.67 C Unresolved disorder model. using A ATOM 493 CA BTHR 59 3.308 -38.933 -2.431 0.50 16.13 C Unresolved disorder model. using A ATOM 496 CB ATHR 59 3.008 -40.268 -1.778 0.50 17.35 C Unresolved disorder model. using A ATOM 497 CB BTHR 59 2.751 -40.126 -1.601 0.50 19.26 C Unresolved disorder model. using A ATOM 498 OG1ATHR 59 1.710 -40.682 -2.258 0.50 11.89 O Unresolved disorder model. using A ATOM 499 OG1BTHR 59 2.311 -39.624 -0.320 0.50 20.98 O Unresolved disorder model. using A ATOM 500 CG2ATHR 59 3.061 -40.189 -0.215 0.50 16.93 C Unresolved disorder model. using A ATOM 501 CG2BTHR 59 3.756 -41.195 -1.419 0.50 17.50 C Unresolved disorder model. using A ATOM 568 CA ATHR 69 6.089 -46.775 7.758 0.50 17.03 C Unresolved disorder model. using A ATOM 569 CA BTHR 69 6.098 -46.722 7.802 0.50 17.97 C Unresolved disorder model. using A ATOM 572 CB ATHR 69 7.399 -47.395 7.304 0.50 17.11 C Unresolved disorder model. using A ATOM 573 CB BTHR 69 7.612 -47.080 7.509 0.50 18.52 C Unresolved disorder model. using A ATOM 574 OG1ATHR 69 7.454 -48.800 7.694 0.50 20.54 O Unresolved disorder model. using A ATOM 575 OG1BTHR 69 7.814 -47.351 6.124 0.50 22.58 O Unresolved disorder model. using A ATOM 576 CG2ATHR 69 8.602 -46.626 7.849 0.50 14.81 C Unresolved disorder model. using A ATOM 577 CG2BTHR 69 8.232 -48.245 8.381 0.50 20.73 C Unresolved disorder model. using A ATOM 656 CA ALYS 80 -1.939 -35.285 5.532 0.50 21.28 C Unresolved disorder model. using A ATOM 657 CA BLYS 80 -1.925 -35.259 5.513 0.50 21.33 C Unresolved disorder model. using A ATOM 660 CB ALYS 80 -3.072 -34.361 5.116 0.50 21.58 C Unresolved disorder model. using A ATOM 661 CB BLYS 80 -2.926 -34.250 5.036 0.50 21.23 C Unresolved disorder model. using A ATOM 662 CG ALYS 80 -4.213 -35.054 4.298 0.50 20.80 C Unresolved disorder model. using A ATOM 663 CG BLYS 80 -3.697 -33.690 6.145 0.50 21.44 C Unresolved disorder model. using A ATOM 664 CD ALYS 80 -5.223 -33.995 3.957 0.50 28.26 C Unresolved disorder model. using A ATOM 665 CD BLYS 80 -4.906 -32.991 5.576 0.50 25.94 C Unresolved disorder model. using A ATOM 666 CE ALYS 80 -6.312 -34.537 3.048 0.50 30.07 C Unresolved disorder model. using A ATOM 667 CE BLYS 80 -5.339 -31.921 6.539 0.50 23.67 C Unresolved disorder model. using A ATOM 668 NZ ALYS 80 -7.289 -35.245 3.938 0.50 31.10 N Unresolved disorder model. using A ATOM 669 NZ BLYS 80 -5.785 -30.788 5.700 0.50 32.81 N Unresolved disorder model. using A ATOM 701 CA AILE 85 -2.150 -38.202 -9.192 0.50 41.17 C Unresolved disorder model. using A ATOM 702 CA BILE 85 -2.078 -38.178 -9.223 0.50 42.05 C Unresolved disorder model. using A ATOM 705 CB AILE 85 -3.542 -38.954 -9.057 0.50 41.40 C Unresolved disorder model. using A ATOM 706 CB BILE 85 -3.355 -39.079 -9.329 0.50 42.78 C Unresolved disorder model. using A ATOM 707 CG1AILE 85 -3.348 -40.420 -8.568 0.50 37.16 C Unresolved disorder model. using A ATOM 708 CG1BILE 85 -4.116 -38.797 -10.623 0.50 42.76 C Unresolved disorder model. using A ATOM 709 CG2AILE 85 -4.337 -38.902 -10.370 0.50 41.62 C Unresolved disorder model. using A ATOM 710 CG2BILE 85 -4.294 -38.915 -8.161 0.50 42.82 C Unresolved disorder model. using A ATOM 711 CD1AILE 85 -4.605 -41.158 -8.040 0.50 30.40 C Unresolved disorder model. using A ATOM 712 CD1BILE 85 -3.408 -39.279 -11.800 0.50 40.60 C Unresolved disorder model. using A ATOM 782 N AILE 95 7.069 -32.059 -13.108 0.50 38.46 N Unresolved disorder model. using A ATOM 783 N BILE 95 7.102 -32.068 -13.111 0.50 38.03 N Unresolved disorder model. using A ATOM 784 CA AILE 95 7.935 -32.972 -12.332 0.50 37.75 C Unresolved disorder model. using A ATOM 785 CA BILE 95 8.032 -32.906 -12.323 0.50 36.76 C Unresolved disorder model. using A ATOM 786 C AILE 95 9.099 -33.431 -13.242 0.50 36.72 C Unresolved disorder model. using A ATOM 787 C BILE 95 9.145 -33.419 -13.258 0.50 36.18 C Unresolved disorder model. using A ATOM 788 O AILE 95 10.264 -33.369 -12.856 0.50 36.28 O Unresolved disorder model. using A ATOM 789 O BILE 95 10.323 -33.389 -12.905 0.50 35.69 O Unresolved disorder model. using A ATOM 790 CB AILE 95 7.132 -34.182 -11.784 0.50 38.26 C Unresolved disorder model. using A ATOM 791 CB BILE 95 7.305 -34.052 -11.628 0.50 37.07 C Unresolved disorder model. using A ATOM 792 CG1AILE 95 6.289 -33.769 -10.554 0.50 38.03 C Unresolved disorder model. using A ATOM 793 CG1BILE 95 6.166 -33.475 -10.793 0.50 35.44 C Unresolved disorder model. using A ATOM 794 CG2AILE 95 8.054 -35.342 -11.419 0.50 38.05 C Unresolved disorder model. using A ATOM 795 CG2BILE 95 8.238 -34.793 -10.668 0.50 34.74 C Unresolved disorder model. using A ATOM 796 CD1AILE 95 6.080 -34.926 -9.526 0.50 39.51 C Unresolved disorder model. using A ATOM 797 CD1BILE 95 6.658 -32.443 -9.887 0.50 33.98 C Unresolved disorder model. using A ATOM 847 N ALEU 102 17.382 -30.568 -12.519 0.50 24.06 N Unresolved disorder model. using A ATOM 848 N BLEU 102 17.352 -30.559 -12.544 0.50 23.47 N Unresolved disorder model. using A ATOM 849 CA ALEU 102 18.291 -30.956 -11.422 0.50 21.93 C Unresolved disorder model. using A ATOM 850 CA BLEU 102 18.205 -30.934 -11.435 0.50 20.83 C Unresolved disorder model. using A ATOM 851 C ALEU 102 19.455 -31.732 -11.939 0.50 21.45 C Unresolved disorder model. using A ATOM 852 C BLEU 102 19.389 -31.757 -11.899 0.50 20.67 C Unresolved disorder model. using A ATOM 853 O ALEU 102 20.609 -31.498 -11.569 0.50 18.84 O Unresolved disorder model. using A ATOM 854 O BLEU 102 20.504 -31.566 -11.453 0.50 18.10 O Unresolved disorder model. using A ATOM 855 CB ALEU 102 17.579 -31.829 -10.380 0.50 21.69 C Unresolved disorder model. using A ATOM 856 CB BLEU 102 17.376 -31.728 -10.432 0.50 19.94 C Unresolved disorder model. using A ATOM 857 CG ALEU 102 16.765 -31.002 -9.406 0.50 23.54 C Unresolved disorder model. using A ATOM 858 CG BLEU 102 18.114 -32.086 -9.175 0.50 18.74 C Unresolved disorder model. using A ATOM 859 CD1ALEU 102 16.034 -31.873 -8.411 0.50 25.84 C Unresolved disorder model. using A ATOM 860 CD1BLEU 102 18.642 -30.865 -8.442 0.50 14.29 C Unresolved disorder model. using A ATOM 861 CD2ALEU 102 17.746 -30.020 -8.670 0.50 26.82 C Unresolved disorder model. using A ATOM 862 CD2BLEU 102 17.176 -32.939 -8.250 0.50 18.56 C Unresolved disorder model. using A ATOM 1177 CA AASP 142 7.389 -14.925 1.812 0.50 26.31 C Unresolved disorder model. using A ATOM 1178 CA BASP 142 7.424 -14.917 1.773 0.50 25.75 C Unresolved disorder model. using A ATOM 1181 CB AASP 142 7.476 -14.104 0.534 0.50 27.46 C Unresolved disorder model. using A ATOM 1182 CB BASP 142 7.634 -14.183 0.440 0.50 26.46 C Unresolved disorder model. using A ATOM 1183 CG AASP 142 6.311 -13.072 0.413 0.50 31.31 C Unresolved disorder model. using A ATOM 1184 CG BASP 142 8.816 -13.165 0.473 0.50 27.70 C Unresolved disorder model. using A ATOM 1185 OD1AASP 142 6.190 -12.222 1.324 0.50 36.32 O Unresolved disorder model. using A ATOM 1186 OD1BASP 142 9.356 -12.890 1.565 0.50 31.57 O Unresolved disorder model. using A ATOM 1187 OD2AASP 142 5.516 -13.148 -0.553 0.50 35.14 O Unresolved disorder model. using A ATOM 1188 OD2BASP 142 9.235 -12.661 -0.605 0.50 32.78 O Unresolved disorder model. using A ATOM 1283 CA AGLN 155 25.981 -20.955 15.463 0.60 15.82 C Unresolved disorder model. using A ATOM 1284 CA BGLN 155 26.023 -20.955 15.341 0.40 16.38 C Unresolved disorder model. using A ATOM 1287 CB AGLN 155 25.509 -20.647 16.901 0.60 15.72 C Unresolved disorder model. using A ATOM 1288 CB BGLN 155 25.762 -20.501 16.752 0.40 16.77 C Unresolved disorder model. using A ATOM 1289 CG AGLN 155 26.460 -21.261 18.009 0.60 18.44 C Unresolved disorder model. using A ATOM 1290 CG BGLN 155 26.921 -20.799 17.635 0.40 18.19 C Unresolved disorder model. using A ATOM 1291 CD AGLN 155 27.918 -20.708 17.988 0.60 20.44 C Unresolved disorder model. using A ATOM 1292 CD BGLN 155 26.975 -19.907 18.795 0.40 19.69 C Unresolved disorder model. using A ATOM 1293 OE1AGLN 155 28.913 -21.490 17.834 0.60 22.67 O Unresolved disorder model. using A ATOM 1294 OE1BGLN 155 26.714 -18.726 18.673 0.40 26.52 O Unresolved disorder model. using A ATOM 1295 NE2AGLN 155 28.056 -19.366 18.149 0.60 16.59 N Unresolved disorder model. using A ATOM 1296 NE2BGLN 155 27.365 -20.447 19.937 0.40 26.35 N Unresolved disorder model. using A ATOM 1401 N AVAL 170 22.243 -23.584 14.923 0.60 15.80 N Unresolved disorder model. using A ATOM 1402 N BVAL 170 22.189 -23.613 14.966 0.40 14.10 N Unresolved disorder model. using A ATOM 1403 CA AVAL 170 21.155 -22.747 15.464 0.60 15.66 C Unresolved disorder model. using A ATOM 1404 CA BVAL 170 21.019 -22.874 15.469 0.40 12.74 C Unresolved disorder model. using A ATOM 1405 C AVAL 170 21.129 -21.434 14.748 0.60 15.53 C Unresolved disorder model. using A ATOM 1406 C BVAL 170 21.061 -21.475 14.936 0.40 13.77 C Unresolved disorder model. using A ATOM 1407 O AVAL 170 22.196 -20.740 14.520 0.60 14.50 O Unresolved disorder model. using A ATOM 1408 O BVAL 170 22.137 -20.804 14.973 0.40 13.98 O Unresolved disorder model. using A ATOM 1409 CB AVAL 170 21.364 -22.488 16.989 0.60 16.63 C Unresolved disorder model. using A ATOM 1410 CB BVAL 170 20.969 -22.913 17.003 0.40 10.89 C Unresolved disorder model. using A ATOM 1411 CG1AVAL 170 20.169 -21.644 17.626 0.60 17.50 C Unresolved disorder model. using A ATOM 1412 CG1BVAL 170 22.320 -22.325 17.598 0.40 11.55 C Unresolved disorder model. using A ATOM 1413 CG2AVAL 170 21.689 -23.751 17.726 0.60 21.43 C Unresolved disorder model. using A ATOM 1414 CG2BVAL 170 19.732 -22.117 17.529 0.40 12.56 C Unresolved disorder model. using A ATOM 1482 CA AGLU 180 22.235 -34.517 12.218 0.50 13.64 C Unresolved disorder model. using A ATOM 1483 CA BGLU 180 22.228 -34.512 12.232 0.50 13.99 C Unresolved disorder model. using A ATOM 1486 CB AGLU 180 22.921 -34.397 10.832 0.50 15.43 C Unresolved disorder model. using A ATOM 1487 CB BGLU 180 22.951 -34.357 10.895 0.50 15.79 C Unresolved disorder model. using A ATOM 1488 CG AGLU 180 24.412 -34.026 10.866 0.50 14.07 C Unresolved disorder model. using A ATOM 1489 CG BGLU 180 22.143 -33.664 9.788 0.50 16.58 C Unresolved disorder model. using A ATOM 1490 CD AGLU 180 25.228 -34.120 9.500 0.50 18.26 C Unresolved disorder model. using A ATOM 1491 CD BGLU 180 20.913 -34.442 9.323 0.50 21.77 C Unresolved disorder model. using A ATOM 1492 OE1AGLU 180 24.703 -34.203 8.389 0.50 12.59 O Unresolved disorder model. using A ATOM 1493 OE1BGLU 180 20.848 -35.627 9.627 0.50 24.96 O Unresolved disorder model. using A ATOM 1494 OE2AGLU 180 26.466 -34.005 9.516 0.50 17.72 O Unresolved disorder model. using A ATOM 1495 OE2BGLU 180 19.983 -33.850 8.701 0.50 21.44 O Unresolved disorder model. using A ATOM 1523 N AGLU 185 32.867 -35.923 14.760 0.50 21.58 N Unresolved disorder model. using A ATOM 1524 N BGLU 185 32.929 -35.880 14.711 0.50 22.83 N Unresolved disorder model. using A ATOM 1525 CA AGLU 185 32.961 -34.699 14.076 0.50 21.64 C Unresolved disorder model. using A ATOM 1526 CA BGLU 185 32.934 -34.501 14.108 0.50 24.32 C Unresolved disorder model. using A ATOM 1527 C AGLU 185 34.261 -34.791 13.318 0.50 20.32 C Unresolved disorder model. using A ATOM 1528 C BGLU 185 34.190 -34.132 13.264 0.50 22.88 C Unresolved disorder model. using A ATOM 1529 O AGLU 185 35.326 -35.112 13.957 0.50 17.52 O Unresolved disorder model. using A ATOM 1530 O BGLU 185 35.193 -33.592 13.762 0.50 25.60 O Unresolved disorder model. using A ATOM 1531 CB AGLU 185 32.984 -33.506 15.049 0.50 19.80 C Unresolved disorder model. using A ATOM 1532 CB BGLU 185 32.674 -33.401 15.171 0.50 22.38 C Unresolved disorder model. using A ATOM 1533 CG AGLU 185 32.585 -32.242 14.344 0.50 22.42 C Unresolved disorder model. using A ATOM 1534 CG BGLU 185 32.506 -31.990 14.573 0.50 26.88 C Unresolved disorder model. using A ATOM 1535 CD AGLU 185 32.572 -31.002 15.239 0.50 20.96 C Unresolved disorder model. using A ATOM 1536 CD BGLU 185 32.373 -30.842 15.604 0.50 29.23 C Unresolved disorder model. using A ATOM 1537 OE1AGLU 185 33.451 -30.824 16.144 0.50 21.40 O Unresolved disorder model. using A ATOM 1538 OE1BGLU 185 32.748 -30.989 16.796 0.50 26.67 O Unresolved disorder model. using A ATOM 1539 OE2AGLU 185 31.660 -30.182 15.035 0.50 16.04 O Unresolved disorder model. using A ATOM 1540 OE2BGLU 185 31.903 -29.754 15.203 0.50 30.70 O Unresolved disorder model. using A ATOM 1622 CA ALYS 196 23.040 -28.686 3.278 0.50 11.89 C Unresolved disorder model. using A ATOM 1623 CA BLYS 196 23.007 -28.644 3.193 0.50 12.33 C Unresolved disorder model. using A ATOM 1626 CB ALYS 196 22.958 -29.852 4.275 0.50 10.29 C Unresolved disorder model. using A ATOM 1627 CB BLYS 196 22.666 -29.942 3.945 0.50 12.72 C Unresolved disorder model. using A ATOM 1628 CG ALYS 196 23.454 -31.178 3.620 0.50 11.18 C Unresolved disorder model. using A ATOM 1629 CG BLYS 196 22.850 -31.174 3.050 0.50 13.26 C Unresolved disorder model. using A ATOM 1630 CD ALYS 196 22.777 -32.332 4.360 0.50 10.23 C Unresolved disorder model. using A ATOM 1631 CD BLYS 196 22.706 -32.574 3.750 0.50 16.87 C Unresolved disorder model. using A ATOM 1632 CE ALYS 196 23.483 -32.548 5.569 0.50 6.67 C Unresolved disorder model. using A ATOM 1633 CE BLYS 196 21.372 -32.633 4.460 0.50 22.35 C Unresolved disorder model. using A ATOM 1634 NZ ALYS 196 22.833 -33.750 6.244 0.50 12.18 N Unresolved disorder model. using A ATOM 1635 NZ BLYS 196 20.815 -33.960 4.864 0.50 23.40 N Unresolved disorder model. using A ATOM 1709 CA AVAL 206 28.495 -19.135 10.739 0.50 16.43 C Unresolved disorder model. using A ATOM 1710 CA BVAL 206 28.481 -19.123 10.778 0.50 17.39 C Unresolved disorder model. using A ATOM 1713 CB AVAL 206 28.686 -20.446 9.976 0.50 16.87 C Unresolved disorder model. using A ATOM 1714 CB BVAL 206 28.626 -20.549 10.174 0.50 18.08 C Unresolved disorder model. using A ATOM 1715 CG1AVAL 206 29.113 -21.676 10.870 0.50 15.74 C Unresolved disorder model. using A ATOM 1716 CG1BVAL 206 29.926 -20.756 9.428 0.50 18.07 C Unresolved disorder model. using A ATOM 1717 CG2AVAL 206 27.369 -20.777 9.206 0.50 12.12 C Unresolved disorder model. using A ATOM 1718 CG2BVAL 206 28.475 -21.687 11.276 0.50 17.09 C Unresolved disorder model. using A ATOM 1719 N AHIS 207 29.150 -19.018 13.061 0.70 17.53 N Unresolved disorder model. using A ATOM 1720 N BHIS 207 29.179 -19.005 13.074 0.30 17.62 N Unresolved disorder model. using A ATOM 1721 CA AHIS 207 30.098 -19.074 14.173 0.70 19.51 C Unresolved disorder model. using A ATOM 1722 CA BHIS 207 30.104 -18.979 14.212 0.30 17.57 C Unresolved disorder model. using A ATOM 1723 C AHIS 207 30.400 -20.551 14.335 0.70 18.22 C Unresolved disorder model. using A ATOM 1724 C BHIS 207 30.457 -20.434 14.525 0.30 17.17 C Unresolved disorder model. using A ATOM 1725 O AHIS 207 29.494 -21.385 14.604 0.70 18.99 O Unresolved disorder model. using A ATOM 1726 O BHIS 207 29.610 -21.112 15.151 0.30 16.63 O Unresolved disorder model. using A ATOM 1727 CB AHIS 207 29.500 -18.436 15.407 0.70 20.60 C Unresolved disorder model. using A ATOM 1728 CB BHIS 207 29.390 -18.347 15.402 0.30 18.04 C Unresolved disorder model. using A ATOM 1729 CG AHIS 207 29.388 -16.934 15.301 0.70 25.09 C Unresolved disorder model. using A ATOM 1730 CG BHIS 207 29.066 -16.889 15.211 0.30 17.86 C Unresolved disorder model. using A ATOM 1731 ND1AHIS 207 30.452 -16.081 15.556 0.70 28.24 N Unresolved disorder model. using A ATOM 1732 ND1BHIS 207 28.162 -16.207 16.001 0.30 17.09 N Unresolved disorder model. using A ATOM 1733 CD2AHIS 207 28.363 -16.143 14.894 0.70 27.32 C Unresolved disorder model. using A ATOM 1734 CD2BHIS 207 29.510 -15.996 14.289 0.30 18.13 C Unresolved disorder model. using A ATOM 1735 CE1AHIS 207 30.075 -14.828 15.353 0.70 33.41 C Unresolved disorder model. using A ATOM 1736 CE1BHIS 207 28.107 -14.944 15.616 0.30 16.28 C Unresolved disorder model. using A ATOM 1737 NE2AHIS 207 28.819 -14.836 14.931 0.70 34.02 N Unresolved disorder model. using A ATOM 1738 NE2BHIS 207 28.902 -14.792 14.561 0.30 17.56 N Unresolved disorder model. using A ATOM 1740 CA ATHR 208 32.052 -22.350 14.177 0.50 15.88 C Unresolved disorder model. using A ATOM 1741 CA BTHR 208 32.029 -22.314 14.171 0.50 17.58 C Unresolved disorder model. using A ATOM 1744 CB ATHR 208 33.428 -22.708 13.495 0.50 18.69 C Unresolved disorder model. using A ATOM 1745 CB BTHR 208 33.322 -22.487 13.342 0.50 20.57 C Unresolved disorder model. using A ATOM 1746 OG1ATHR 208 34.428 -21.815 14.020 0.50 11.88 O Unresolved disorder model. using A ATOM 1747 OG1BTHR 208 33.179 -21.750 12.115 0.50 22.05 O Unresolved disorder model. using A ATOM 1748 CG2ATHR 208 33.371 -22.666 11.909 0.50 17.18 C Unresolved disorder model. using A ATOM 1749 CG2BTHR 208 33.617 -23.899 13.047 0.50 20.63 C Unresolved disorder model. using A ATOM 1816 CA ATHR 218 37.432 -28.655 3.961 0.50 16.39 C Unresolved disorder model. using A ATOM 1817 CA BTHR 218 37.385 -28.657 3.930 0.50 17.42 C Unresolved disorder model. using A ATOM 1820 CB ATHR 218 37.290 -30.098 4.401 0.50 16.70 C Unresolved disorder model. using A ATOM 1821 CB BTHR 218 36.958 -30.159 4.235 0.50 18.49 C Unresolved disorder model. using A ATOM 1822 OG1ATHR 218 38.479 -30.864 4.000 0.50 20.60 O Unresolved disorder model. using A ATOM 1823 OG1BTHR 218 37.086 -30.465 5.620 0.50 23.58 O Unresolved disorder model. using A ATOM 1824 CG2ATHR 218 36.011 -30.714 3.818 0.50 15.17 C Unresolved disorder model. using A ATOM 1825 CG2BTHR 218 37.705 -31.302 3.377 0.50 20.82 C Unresolved disorder model. using A ATOM 1904 CA ALYS 229 31.510 -15.929 6.202 0.50 21.11 C Unresolved disorder model. using A ATOM 1905 CA BLYS 229 31.543 -15.942 6.157 0.50 20.83 C Unresolved disorder model. using A ATOM 1908 CB ALYS 229 31.144 -14.552 6.706 0.50 21.46 C Unresolved disorder model. using A ATOM 1909 CB BLYS 229 31.350 -14.465 6.513 0.50 21.12 C Unresolved disorder model. using A ATOM 1910 CG ALYS 229 30.928 -13.624 5.605 0.50 21.19 C Unresolved disorder model. using A ATOM 1911 CG BLYS 229 32.504 -13.866 7.344 0.50 19.31 C Unresolved disorder model. using A ATOM 1912 CD ALYS 229 31.107 -12.169 6.076 0.50 28.20 C Unresolved disorder model. using A ATOM 1913 CD BLYS 229 32.190 -12.381 7.657 0.50 27.87 C Unresolved disorder model. using A ATOM 1914 CE ALYS 229 30.231 -11.277 5.211 0.50 26.82 C Unresolved disorder model. using A ATOM 1915 CE BLYS 229 33.067 -11.868 8.794 0.50 27.18 C Unresolved disorder model. using A ATOM 1916 NZ ALYS 229 30.854 -9.914 5.082 0.50 35.68 N Unresolved disorder model. using A ATOM 1917 NZ BLYS 229 32.483 -10.619 9.407 0.50 31.14 N Unresolved disorder model. using A ATOM 1948 N AILE 234 33.733 -17.690 19.666 0.50 41.23 N Unresolved disorder model. using A ATOM 1949 N BILE 234 33.733 -17.699 19.674 0.50 41.85 N Unresolved disorder model. using A ATOM 1950 CA AILE 234 34.168 -17.265 21.003 0.50 43.13 C Unresolved disorder model. using A ATOM 1951 CA BILE 234 34.133 -17.346 21.031 0.50 44.39 C Unresolved disorder model. using A ATOM 1952 C AILE 234 33.002 -16.472 21.625 0.50 45.52 C Unresolved disorder model. using A ATOM 1953 C BILE 234 33.036 -16.479 21.645 0.50 46.16 C Unresolved disorder model. using A ATOM 1954 O AILE 234 32.490 -15.544 20.993 0.50 45.33 O Unresolved disorder model. using A ATOM 1955 O BILE 234 32.607 -15.497 21.031 0.50 46.12 O Unresolved disorder model. using A ATOM 1956 CB AILE 234 35.518 -16.464 20.942 0.50 43.01 C Unresolved disorder model. using A ATOM 1957 CB BILE 234 35.553 -16.725 21.106 0.50 44.69 C Unresolved disorder model. using A ATOM 1958 CG1AILE 234 36.665 -17.359 20.400 0.50 38.19 C Unresolved disorder model. using A ATOM 1959 CG1BILE 234 35.775 -16.075 22.465 0.50 44.17 C Unresolved disorder model. using A ATOM 1960 CG2AILE 234 35.875 -15.883 22.319 0.50 43.34 C Unresolved disorder model. using A ATOM 1961 CG2BILE 234 35.797 -15.734 19.997 0.50 44.26 C Unresolved disorder model. using A ATOM 1962 CD1AILE 234 37.875 -16.635 19.775 0.50 31.38 C Unresolved disorder model. using A ATOM 1963 CD1BILE 234 35.528 -17.012 23.535 0.50 40.72 C Unresolved disorder model. using A ATOM 2033 N AILE 244 24.268 -22.226 24.862 0.50 38.34 N Unresolved disorder model. using A ATOM 2034 N BILE 244 24.281 -22.208 24.877 0.50 38.22 N Unresolved disorder model. using A ATOM 2035 CA AILE 244 24.495 -23.460 24.082 0.50 37.55 C Unresolved disorder model. using A ATOM 2036 CA BILE 244 24.607 -23.442 24.132 0.50 37.48 C Unresolved disorder model. using A ATOM 2037 C AILE 244 24.380 -24.694 25.021 0.50 36.71 C Unresolved disorder model. using A ATOM 2038 C BILE 244 24.367 -24.659 25.034 0.50 36.68 C Unresolved disorder model. using A ATOM 2039 O AILE 244 23.789 -25.705 24.648 0.50 35.57 O Unresolved disorder model. using A ATOM 2040 O BILE 244 23.692 -25.614 24.654 0.50 35.73 O Unresolved disorder model. using A ATOM 2041 CB AILE 244 25.833 -23.398 23.325 0.50 38.14 C Unresolved disorder model. using A ATOM 2042 CB BILE 244 26.065 -23.396 23.662 0.50 37.79 C Unresolved disorder model. using A ATOM 2043 CG1AILE 244 25.910 -22.109 22.503 0.50 37.25 C Unresolved disorder model. using A ATOM 2044 CG1BILE 244 26.195 -22.287 22.619 0.50 36.74 C Unresolved disorder model. using A ATOM 2045 CG2AILE 244 26.018 -24.587 22.385 0.50 37.10 C Unresolved disorder model. using A ATOM 2046 CG2BILE 244 26.534 -24.737 23.097 0.50 37.49 C Unresolved disorder model. using A ATOM 2047 CD1AILE 244 27.298 -21.871 21.863 0.50 38.86 C Unresolved disorder model. using A ATOM 2048 CD1BILE 244 25.040 -22.246 21.677 0.50 35.05 C Unresolved disorder model. using A ATOM 2081 CA ALYS 249 20.482 -30.112 27.740 0.50 24.47 C Unresolved disorder model. using A ATOM 2082 CA BLYS 249 20.498 -30.144 27.725 0.50 24.61 C Unresolved disorder model. using A ATOM 2085 CB ALYS 249 20.557 -29.281 29.037 0.50 26.07 C Unresolved disorder model. using A ATOM 2086 CB BLYS 249 20.633 -29.410 29.078 0.50 26.13 C Unresolved disorder model. using A ATOM 2087 CG ALYS 249 19.755 -29.834 30.210 0.50 26.45 C Unresolved disorder model. using A ATOM 2088 CG BLYS 249 22.071 -29.154 29.522 0.50 27.71 C Unresolved disorder model. using A ATOM 2089 CD ALYS 249 20.183 -29.100 31.487 0.50 30.99 C Unresolved disorder model. using A ATOM 2090 CD BLYS 249 22.107 -28.508 30.938 0.50 28.05 C Unresolved disorder model. using A ATOM 2091 CE ALYS 249 19.052 -29.044 32.513 0.50 33.27 C Unresolved disorder model. using A ATOM 2092 CE BLYS 249 23.036 -27.230 31.006 0.50 32.51 C Unresolved disorder model. using A ATOM 2093 NZ ALYS 249 19.592 -29.169 33.900 0.50 36.01 N Unresolved disorder model. using A ATOM 2094 NZ BLYS 249 22.310 -26.004 31.534 0.50 29.75 N Unresolved disorder model. using A ATOM 2104 N ALEU 251 17.794 -30.334 24.293 0.50 23.09 N Unresolved disorder model. using A ATOM 2105 N BLEU 251 17.813 -30.304 24.330 0.50 22.47 N Unresolved disorder model. using A ATOM 2106 CA ALEU 251 17.658 -31.308 23.202 0.50 21.57 C Unresolved disorder model. using A ATOM 2107 CA BLEU 251 17.709 -31.193 23.208 0.50 20.48 C Unresolved disorder model. using A ATOM 2108 C ALEU 251 17.727 -32.692 23.746 0.50 21.28 C Unresolved disorder model. using A ATOM 2109 C BLEU 251 17.868 -32.650 23.629 0.50 20.34 C Unresolved disorder model. using A ATOM 2110 O ALEU 251 16.891 -33.551 23.422 0.50 18.08 O Unresolved disorder model. using A ATOM 2111 O BLEU 251 17.222 -33.531 23.092 0.50 16.85 O Unresolved disorder model. using A ATOM 2112 CB ALEU 251 18.776 -31.162 22.146 0.50 21.32 C Unresolved disorder model. using A ATOM 2113 CB BLEU 251 18.779 -30.800 22.175 0.50 19.80 C Unresolved disorder model. using A ATOM 2114 CG ALEU 251 18.442 -30.062 21.175 0.50 23.11 C Unresolved disorder model. using A ATOM 2115 CG BLEU 251 18.770 -31.697 20.986 0.50 17.71 C Unresolved disorder model. using A ATOM 2116 CD1ALEU 251 19.545 -29.863 20.162 0.50 23.34 C Unresolved disorder model. using A ATOM 2117 CD1BLEU 251 17.442 -31.550 20.203 0.50 14.19 C Unresolved disorder model. using A ATOM 2118 CD2ALEU 251 17.054 -30.398 20.458 0.50 23.30 C Unresolved disorder model. using A ATOM 2119 CD2BLEU 251 20.001 -31.377 20.067 0.50 18.91 C Unresolved disorder model. using A ATOM 2434 CA AASP 291 9.243 -13.831 9.971 0.60 26.45 C Unresolved disorder model. using A ATOM 2435 CA BASP 291 9.219 -13.868 9.941 0.40 25.00 C Unresolved disorder model. using A ATOM 2438 CB AASP 291 8.607 -13.553 11.343 0.60 27.62 C Unresolved disorder model. using A ATOM 2439 CB BASP 291 8.440 -13.676 11.261 0.40 25.14 C Unresolved disorder model. using A ATOM 2440 CG AASP 291 8.401 -12.005 11.620 0.60 34.59 C Unresolved disorder model. using A ATOM 2441 CG BASP 291 6.986 -14.240 11.206 0.40 25.33 C Unresolved disorder model. using A ATOM 2442 OD1AASP 291 7.660 -11.360 10.854 0.60 39.74 O Unresolved disorder model. using A ATOM 2443 OD1BASP 291 6.490 -14.522 10.102 0.40 27.33 O Unresolved disorder model. using A ATOM 2444 OD2AASP 291 9.003 -11.426 12.572 0.60 39.83 O Unresolved disorder model. using A ATOM 2445 OD2BASP 291 6.344 -14.440 12.260 0.40 28.44 O 1